Redwood Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,117
Closed -$582K 293
2021
Q3
$582K Hold
7,117
0.08% 234
2021
Q2
$649K Hold
7,117
0.11% 210
2021
Q1
$608K Buy
+7,117
New +$639K 0.12% 228
2020
Q1
Sell
-6,050
Closed -$573K 227
2019
Q4
$573K Buy
6,050
+97
+2% +$8.7K 0.14% 176
2019
Q3
$517K Hold
5,953
0.14% 174
2019
Q2
$544K Buy
5,953
+288
+5% +$24.4K 0.15% 171
2019
Q1
$488K Buy
+5,665
New +$455K 0.21% 89
2018
Q1
Sell
-3,547
Closed -$267K 139
2017
Q4
$267K Buy
+3,547
New +$268K 0.12% 91

Other funds holding NVS

Redwood Investment Management's NVS Position: Q4 2021 in Review

Redwood Investment Management sold out of Novartis (NVS) in Q4 2021, closing a stake of 7,117 shares — an estimated $582K sold.

Redwood Investment Management first reported a position in NVS in Q4 2017 and held it in 8 quarters. The position peaked at $649K in Q2 2021. 1,147 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

  • Redwood Investment Management reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
  • Redwood Investment Management sold 7,117 Novartis shares in Q4 2021, an estimated $582K.
  • Redwood Investment Management first reported a position in Novartis in Q4 2017 and held it in 8 quarters.
  • Redwood Investment Management's Novartis position peaked at $649K in Q2 2021.
  • 1,147 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Redwood Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.